• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE INTERING® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE INTERING® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number ISRT-4645L
Device Problem Difficult to Remove (1528)
Patient Problems Edema (1820); Pain (1994); Seroma (2069); Stenosis (2263); Fluid Discharge (2686); Foreign Body In Patient (2687)
Event Date 07/06/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).A review of the manufacturing records for the device verified that the lot met all pre-release specifications.An explant evaluation is currently in process.
 
Event Description
On (b)(6) 2015, a patient was implanted with a gore-tex intering stretch vascular graft for av access.No clamp was made on the graft.A slider sheath was used to place the graft in position.Edema was observed on his left upper arm postoperatively.The physician determined to monitor the patient.On (b)(6) 2015, a stenosis in the vein close to the anastomotic site was observed.On (b)(6) 2015, the patient presented with a pain in the upper arm.A surgical intervention was performed, and a seroma was observed around the graft close to the anastomotic site of the vein.A drain was placed to treat the seroma.On (b)(6) 2015, the persistent growth in edema and serous fluid leakage was observed.A different drain was placed to treat the seroma.On (b)(6) 2015, the drain was removed.On (b)(6) 2015, the graft was partially replaced with another vascular graft, leaving the 2cm portion anastomosed with the vein.It was reported that the vein was conglutinate with the artery underneath, therefore, the graft could not be removed completely.On (b)(6) 2015, the continuous growth in edema was observed.The physician determined to remove the shunt completely, including the remaining portion of the gore-tex vascular graft and a central intravenous catheter was placed instead.The patient tolerated the procedure.
 
Manufacturer Narrative
The explant evaluation stated that the devices were returned to w.L.Gore & associates for investigation.Submitted in formalin were two gore-tex® intering stretch vascular graft fragments (vgf-1 and vgf-2).Each fragment was approximately 1 cm in length and transected at both poles prior to arrival at w.L.Gore & associates.The lumens of both fragments were widely patent and the luminal surfaces contained a minimal amount of non-adherent red brown tissue.The abluminal surfaces contained multifocal loosely adherent light tan brown tissue.Vgf-2 had a knotted fragment of white suture present at one pole.Histopathological examination of two abluminal tissue specimens from vgf-1 and vgf-2 was performed.Tissue sampled from the abluminal surfaces of the graft segments consisted of a mixture of acute thrombus and seromatous regions.In addition, the graft wall of one of the segments appeared to have been apposed with suture and a bioadhesive was present on the abluminal surface as evidenced by its unique microscopic appearance and eosinophilic inflammatory response.The devices were subjected to an enzymatic digestion process to remove biologic debris.Following digestion the device fragments were examined for material disruptions with the aid of a stereomicroscope.Disruptions identified were not associated with handling or manufacturing process at w.L.Gore and associates.The disruptions are consistent with instruments used as part of a surgical procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE INTERING® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
sandra whicker
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5012669
MDR Text Key23385937
Report Number2017233-2015-00542
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K991683
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Followup
Report Date 10/23/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/29/2020
Device Catalogue NumberISRT-4645L
Device Lot Number13690684
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/10/2015
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/24/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-